| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |